ClinicalTrials.Veeva

Menu

Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment

A

ART Fertility Clinics LLC

Status

Completed

Conditions

Infertility

Study type

Observational

Funder types

Other

Identifiers

NCT03607409
1806-ABU-043-BL

Details and patient eligibility

About

To evaluate the role of Inhibin A as bio marker for the number of mature oocytes, compared to Estradiol

Full description

Inhibin A could be an improved biomarker regarding the number of expected mature oocytes compared to estradiol.

Enrollment

150 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Patients undergoing ovarian stimulation with gonadotropins in either a GnRH-agonist or GnRH-antagonist for IVF treatment due to primary / secondary infertility.

Exclusion criteria

Patients undergoing a modified natural cycle stimulation protocol (Taymour cycle) Patients at risk for development of ovarian hyperstimulation syndrome (OHSS)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems